Medical Care
Global Diabetes Supplements Market Research Report 2025
- Jul 08, 25
- ID: 348821
- Pages: 97
- Figures: 91
- Views: 13
The global market for Diabetes Supplements was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Diabetes, also known diabetes mellitus, is a metabolic disease resulting in high blood sugar. The hormone known as insulin is responsible for the movement of sugar from the blood into the cells, which is stored and used for providing energy to the body. In case of diabetes, body is either unable to produce enough insulin or cannot effectively utilize insulin produced Two main types of diabetes are type 1 diabetes and type 2 diabetes. In case of type 1 diabetes, the immune system attacks and destroys insulin producing cells in the pancreas while in type 2 diabetes patients the body becomes resistant to insulin. Dietary supplements are ingredients that are intended to enhance the diet of a person and contain vitamins, minerals, herbs, amino acids, metabolites, and other substances. These supplements are used for lowering blood glucose, improving cholesterol, lowering blood pressure, neuropathy, insulin resistance, and other complications in diabetic patients.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report aims to provide a comprehensive presentation of the global market for Diabetes Supplements, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Supplements.
The Diabetes Supplements market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Diabetes Supplements market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetes Supplements companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novo Nordisk
Nestlé Health Science
Danone Nutricia
NaturoGain
Nature's Sunshine Forms
Nature's Bounty
Glucose Health, Inc
Unilever(Horlicks Cardia +)
Bionova Lifesciences
Caelus Health
Abbott
Pfizer
Arkopharma Laboratories
GlaxoSmithKline
Archer Daniels Midland
Herbalife International
Segment by Type
By Supplements Type
By Dosage Form
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diabetes Supplements company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Diabetes, also known diabetes mellitus, is a metabolic disease resulting in high blood sugar. The hormone known as insulin is responsible for the movement of sugar from the blood into the cells, which is stored and used for providing energy to the body. In case of diabetes, body is either unable to produce enough insulin or cannot effectively utilize insulin produced Two main types of diabetes are type 1 diabetes and type 2 diabetes. In case of type 1 diabetes, the immune system attacks and destroys insulin producing cells in the pancreas while in type 2 diabetes patients the body becomes resistant to insulin. Dietary supplements are ingredients that are intended to enhance the diet of a person and contain vitamins, minerals, herbs, amino acids, metabolites, and other substances. These supplements are used for lowering blood glucose, improving cholesterol, lowering blood pressure, neuropathy, insulin resistance, and other complications in diabetic patients.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report aims to provide a comprehensive presentation of the global market for Diabetes Supplements, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Supplements.
The Diabetes Supplements market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Diabetes Supplements market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetes Supplements companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novo Nordisk
Nestlé Health Science
Danone Nutricia
NaturoGain
Nature's Sunshine Forms
Nature's Bounty
Glucose Health, Inc
Unilever(Horlicks Cardia +)
Bionova Lifesciences
Caelus Health
Abbott
Pfizer
Arkopharma Laboratories
GlaxoSmithKline
Archer Daniels Midland
Herbalife International
Segment by Type
By Supplements Type
By Dosage Form
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diabetes Supplements company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetes Supplements Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 By Supplements Type
1.2.3 By Dosage Form
1.3 Market by Application
1.3.1 Global Diabetes Supplements Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diabetes Supplements Market Perspective (2020-2031)
2.2 Global Diabetes Supplements Growth Trends by Region
2.2.1 Global Diabetes Supplements Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Diabetes Supplements Historic Market Size by Region (2020-2025)
2.2.3 Diabetes Supplements Forecasted Market Size by Region (2026-2031)
2.3 Diabetes Supplements Market Dynamics
2.3.1 Diabetes Supplements Industry Trends
2.3.2 Diabetes Supplements Market Drivers
2.3.3 Diabetes Supplements Market Challenges
2.3.4 Diabetes Supplements Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetes Supplements Players by Revenue
3.1.1 Global Top Diabetes Supplements Players by Revenue (2020-2025)
3.1.2 Global Diabetes Supplements Revenue Market Share by Players (2020-2025)
3.2 Global Diabetes Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Diabetes Supplements Revenue
3.4 Global Diabetes Supplements Market Concentration Ratio
3.4.1 Global Diabetes Supplements Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetes Supplements Revenue in 2024
3.5 Global Key Players of Diabetes Supplements Head office and Area Served
3.6 Global Key Players of Diabetes Supplements, Product and Application
3.7 Global Key Players of Diabetes Supplements, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetes Supplements Breakdown Data by Type
4.1 Global Diabetes Supplements Historic Market Size by Type (2020-2025)
4.2 Global Diabetes Supplements Forecasted Market Size by Type (2026-2031)
5 Diabetes Supplements Breakdown Data by Application
5.1 Global Diabetes Supplements Historic Market Size by Application (2020-2025)
5.2 Global Diabetes Supplements Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Diabetes Supplements Market Size (2020-2031)
6.2 North America Diabetes Supplements Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Diabetes Supplements Market Size by Country (2020-2025)
6.4 North America Diabetes Supplements Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Diabetes Supplements Market Size (2020-2031)
7.2 Europe Diabetes Supplements Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Diabetes Supplements Market Size by Country (2020-2025)
7.4 Europe Diabetes Supplements Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diabetes Supplements Market Size (2020-2031)
8.2 Asia-Pacific Diabetes Supplements Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Diabetes Supplements Market Size by Region (2020-2025)
8.4 Asia-Pacific Diabetes Supplements Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Diabetes Supplements Market Size (2020-2031)
9.2 Latin America Diabetes Supplements Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Diabetes Supplements Market Size by Country (2020-2025)
9.4 Latin America Diabetes Supplements Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diabetes Supplements Market Size (2020-2031)
10.2 Middle East & Africa Diabetes Supplements Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Diabetes Supplements Market Size by Country (2020-2025)
10.4 Middle East & Africa Diabetes Supplements Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Details
11.1.2 Novo Nordisk Business Overview
11.1.3 Novo Nordisk Diabetes Supplements Introduction
11.1.4 Novo Nordisk Revenue in Diabetes Supplements Business (2020-2025)
11.1.5 Novo Nordisk Recent Development
11.2 Nestlé Health Science
11.2.1 Nestlé Health Science Company Details
11.2.2 Nestlé Health Science Business Overview
11.2.3 Nestlé Health Science Diabetes Supplements Introduction
11.2.4 Nestlé Health Science Revenue in Diabetes Supplements Business (2020-2025)
11.2.5 Nestlé Health Science Recent Development
11.3 Danone Nutricia
11.3.1 Danone Nutricia Company Details
11.3.2 Danone Nutricia Business Overview
11.3.3 Danone Nutricia Diabetes Supplements Introduction
11.3.4 Danone Nutricia Revenue in Diabetes Supplements Business (2020-2025)
11.3.5 Danone Nutricia Recent Development
11.4 NaturoGain
11.4.1 NaturoGain Company Details
11.4.2 NaturoGain Business Overview
11.4.3 NaturoGain Diabetes Supplements Introduction
11.4.4 NaturoGain Revenue in Diabetes Supplements Business (2020-2025)
11.4.5 NaturoGain Recent Development
11.5 Nature's Sunshine Forms
11.5.1 Nature's Sunshine Forms Company Details
11.5.2 Nature's Sunshine Forms Business Overview
11.5.3 Nature's Sunshine Forms Diabetes Supplements Introduction
11.5.4 Nature's Sunshine Forms Revenue in Diabetes Supplements Business (2020-2025)
11.5.5 Nature's Sunshine Forms Recent Development
11.6 Nature's Bounty
11.6.1 Nature's Bounty Company Details
11.6.2 Nature's Bounty Business Overview
11.6.3 Nature's Bounty Diabetes Supplements Introduction
11.6.4 Nature's Bounty Revenue in Diabetes Supplements Business (2020-2025)
11.6.5 Nature's Bounty Recent Development
11.7 Glucose Health, Inc
11.7.1 Glucose Health, Inc Company Details
11.7.2 Glucose Health, Inc Business Overview
11.7.3 Glucose Health, Inc Diabetes Supplements Introduction
11.7.4 Glucose Health, Inc Revenue in Diabetes Supplements Business (2020-2025)
11.7.5 Glucose Health, Inc Recent Development
11.8 Unilever(Horlicks Cardia +)
11.8.1 Unilever(Horlicks Cardia +) Company Details
11.8.2 Unilever(Horlicks Cardia +) Business Overview
11.8.3 Unilever(Horlicks Cardia +) Diabetes Supplements Introduction
11.8.4 Unilever(Horlicks Cardia +) Revenue in Diabetes Supplements Business (2020-2025)
11.8.5 Unilever(Horlicks Cardia +) Recent Development
11.9 Bionova Lifesciences
11.9.1 Bionova Lifesciences Company Details
11.9.2 Bionova Lifesciences Business Overview
11.9.3 Bionova Lifesciences Diabetes Supplements Introduction
11.9.4 Bionova Lifesciences Revenue in Diabetes Supplements Business (2020-2025)
11.9.5 Bionova Lifesciences Recent Development
11.10 Caelus Health
11.10.1 Caelus Health Company Details
11.10.2 Caelus Health Business Overview
11.10.3 Caelus Health Diabetes Supplements Introduction
11.10.4 Caelus Health Revenue in Diabetes Supplements Business (2020-2025)
11.10.5 Caelus Health Recent Development
11.11 Abbott
11.11.1 Abbott Company Details
11.11.2 Abbott Business Overview
11.11.3 Abbott Diabetes Supplements Introduction
11.11.4 Abbott Revenue in Diabetes Supplements Business (2020-2025)
11.11.5 Abbott Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Diabetes Supplements Introduction
11.12.4 Pfizer Revenue in Diabetes Supplements Business (2020-2025)
11.12.5 Pfizer Recent Development
11.13 Arkopharma Laboratories
11.13.1 Arkopharma Laboratories Company Details
11.13.2 Arkopharma Laboratories Business Overview
11.13.3 Arkopharma Laboratories Diabetes Supplements Introduction
11.13.4 Arkopharma Laboratories Revenue in Diabetes Supplements Business (2020-2025)
11.13.5 Arkopharma Laboratories Recent Development
11.14 GlaxoSmithKline
11.14.1 GlaxoSmithKline Company Details
11.14.2 GlaxoSmithKline Business Overview
11.14.3 GlaxoSmithKline Diabetes Supplements Introduction
11.14.4 GlaxoSmithKline Revenue in Diabetes Supplements Business (2020-2025)
11.14.5 GlaxoSmithKline Recent Development
11.15 Archer Daniels Midland
11.15.1 Archer Daniels Midland Company Details
11.15.2 Archer Daniels Midland Business Overview
11.15.3 Archer Daniels Midland Diabetes Supplements Introduction
11.15.4 Archer Daniels Midland Revenue in Diabetes Supplements Business (2020-2025)
11.15.5 Archer Daniels Midland Recent Development
11.16 Herbalife International
11.16.1 Herbalife International Company Details
11.16.2 Herbalife International Business Overview
11.16.3 Herbalife International Diabetes Supplements Introduction
11.16.4 Herbalife International Revenue in Diabetes Supplements Business (2020-2025)
11.16.5 Herbalife International Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetes Supplements Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 By Supplements Type
1.2.3 By Dosage Form
1.3 Market by Application
1.3.1 Global Diabetes Supplements Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diabetes Supplements Market Perspective (2020-2031)
2.2 Global Diabetes Supplements Growth Trends by Region
2.2.1 Global Diabetes Supplements Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Diabetes Supplements Historic Market Size by Region (2020-2025)
2.2.3 Diabetes Supplements Forecasted Market Size by Region (2026-2031)
2.3 Diabetes Supplements Market Dynamics
2.3.1 Diabetes Supplements Industry Trends
2.3.2 Diabetes Supplements Market Drivers
2.3.3 Diabetes Supplements Market Challenges
2.3.4 Diabetes Supplements Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetes Supplements Players by Revenue
3.1.1 Global Top Diabetes Supplements Players by Revenue (2020-2025)
3.1.2 Global Diabetes Supplements Revenue Market Share by Players (2020-2025)
3.2 Global Diabetes Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Diabetes Supplements Revenue
3.4 Global Diabetes Supplements Market Concentration Ratio
3.4.1 Global Diabetes Supplements Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetes Supplements Revenue in 2024
3.5 Global Key Players of Diabetes Supplements Head office and Area Served
3.6 Global Key Players of Diabetes Supplements, Product and Application
3.7 Global Key Players of Diabetes Supplements, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetes Supplements Breakdown Data by Type
4.1 Global Diabetes Supplements Historic Market Size by Type (2020-2025)
4.2 Global Diabetes Supplements Forecasted Market Size by Type (2026-2031)
5 Diabetes Supplements Breakdown Data by Application
5.1 Global Diabetes Supplements Historic Market Size by Application (2020-2025)
5.2 Global Diabetes Supplements Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Diabetes Supplements Market Size (2020-2031)
6.2 North America Diabetes Supplements Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Diabetes Supplements Market Size by Country (2020-2025)
6.4 North America Diabetes Supplements Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Diabetes Supplements Market Size (2020-2031)
7.2 Europe Diabetes Supplements Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Diabetes Supplements Market Size by Country (2020-2025)
7.4 Europe Diabetes Supplements Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diabetes Supplements Market Size (2020-2031)
8.2 Asia-Pacific Diabetes Supplements Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Diabetes Supplements Market Size by Region (2020-2025)
8.4 Asia-Pacific Diabetes Supplements Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Diabetes Supplements Market Size (2020-2031)
9.2 Latin America Diabetes Supplements Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Diabetes Supplements Market Size by Country (2020-2025)
9.4 Latin America Diabetes Supplements Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diabetes Supplements Market Size (2020-2031)
10.2 Middle East & Africa Diabetes Supplements Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Diabetes Supplements Market Size by Country (2020-2025)
10.4 Middle East & Africa Diabetes Supplements Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Details
11.1.2 Novo Nordisk Business Overview
11.1.3 Novo Nordisk Diabetes Supplements Introduction
11.1.4 Novo Nordisk Revenue in Diabetes Supplements Business (2020-2025)
11.1.5 Novo Nordisk Recent Development
11.2 Nestlé Health Science
11.2.1 Nestlé Health Science Company Details
11.2.2 Nestlé Health Science Business Overview
11.2.3 Nestlé Health Science Diabetes Supplements Introduction
11.2.4 Nestlé Health Science Revenue in Diabetes Supplements Business (2020-2025)
11.2.5 Nestlé Health Science Recent Development
11.3 Danone Nutricia
11.3.1 Danone Nutricia Company Details
11.3.2 Danone Nutricia Business Overview
11.3.3 Danone Nutricia Diabetes Supplements Introduction
11.3.4 Danone Nutricia Revenue in Diabetes Supplements Business (2020-2025)
11.3.5 Danone Nutricia Recent Development
11.4 NaturoGain
11.4.1 NaturoGain Company Details
11.4.2 NaturoGain Business Overview
11.4.3 NaturoGain Diabetes Supplements Introduction
11.4.4 NaturoGain Revenue in Diabetes Supplements Business (2020-2025)
11.4.5 NaturoGain Recent Development
11.5 Nature's Sunshine Forms
11.5.1 Nature's Sunshine Forms Company Details
11.5.2 Nature's Sunshine Forms Business Overview
11.5.3 Nature's Sunshine Forms Diabetes Supplements Introduction
11.5.4 Nature's Sunshine Forms Revenue in Diabetes Supplements Business (2020-2025)
11.5.5 Nature's Sunshine Forms Recent Development
11.6 Nature's Bounty
11.6.1 Nature's Bounty Company Details
11.6.2 Nature's Bounty Business Overview
11.6.3 Nature's Bounty Diabetes Supplements Introduction
11.6.4 Nature's Bounty Revenue in Diabetes Supplements Business (2020-2025)
11.6.5 Nature's Bounty Recent Development
11.7 Glucose Health, Inc
11.7.1 Glucose Health, Inc Company Details
11.7.2 Glucose Health, Inc Business Overview
11.7.3 Glucose Health, Inc Diabetes Supplements Introduction
11.7.4 Glucose Health, Inc Revenue in Diabetes Supplements Business (2020-2025)
11.7.5 Glucose Health, Inc Recent Development
11.8 Unilever(Horlicks Cardia +)
11.8.1 Unilever(Horlicks Cardia +) Company Details
11.8.2 Unilever(Horlicks Cardia +) Business Overview
11.8.3 Unilever(Horlicks Cardia +) Diabetes Supplements Introduction
11.8.4 Unilever(Horlicks Cardia +) Revenue in Diabetes Supplements Business (2020-2025)
11.8.5 Unilever(Horlicks Cardia +) Recent Development
11.9 Bionova Lifesciences
11.9.1 Bionova Lifesciences Company Details
11.9.2 Bionova Lifesciences Business Overview
11.9.3 Bionova Lifesciences Diabetes Supplements Introduction
11.9.4 Bionova Lifesciences Revenue in Diabetes Supplements Business (2020-2025)
11.9.5 Bionova Lifesciences Recent Development
11.10 Caelus Health
11.10.1 Caelus Health Company Details
11.10.2 Caelus Health Business Overview
11.10.3 Caelus Health Diabetes Supplements Introduction
11.10.4 Caelus Health Revenue in Diabetes Supplements Business (2020-2025)
11.10.5 Caelus Health Recent Development
11.11 Abbott
11.11.1 Abbott Company Details
11.11.2 Abbott Business Overview
11.11.3 Abbott Diabetes Supplements Introduction
11.11.4 Abbott Revenue in Diabetes Supplements Business (2020-2025)
11.11.5 Abbott Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Diabetes Supplements Introduction
11.12.4 Pfizer Revenue in Diabetes Supplements Business (2020-2025)
11.12.5 Pfizer Recent Development
11.13 Arkopharma Laboratories
11.13.1 Arkopharma Laboratories Company Details
11.13.2 Arkopharma Laboratories Business Overview
11.13.3 Arkopharma Laboratories Diabetes Supplements Introduction
11.13.4 Arkopharma Laboratories Revenue in Diabetes Supplements Business (2020-2025)
11.13.5 Arkopharma Laboratories Recent Development
11.14 GlaxoSmithKline
11.14.1 GlaxoSmithKline Company Details
11.14.2 GlaxoSmithKline Business Overview
11.14.3 GlaxoSmithKline Diabetes Supplements Introduction
11.14.4 GlaxoSmithKline Revenue in Diabetes Supplements Business (2020-2025)
11.14.5 GlaxoSmithKline Recent Development
11.15 Archer Daniels Midland
11.15.1 Archer Daniels Midland Company Details
11.15.2 Archer Daniels Midland Business Overview
11.15.3 Archer Daniels Midland Diabetes Supplements Introduction
11.15.4 Archer Daniels Midland Revenue in Diabetes Supplements Business (2020-2025)
11.15.5 Archer Daniels Midland Recent Development
11.16 Herbalife International
11.16.1 Herbalife International Company Details
11.16.2 Herbalife International Business Overview
11.16.3 Herbalife International Diabetes Supplements Introduction
11.16.4 Herbalife International Revenue in Diabetes Supplements Business (2020-2025)
11.16.5 Herbalife International Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Diabetes Supplements Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of By Supplements Type
Table 3. Key Players of By Dosage Form
Table 4. Global Diabetes Supplements Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Diabetes Supplements Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Diabetes Supplements Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Diabetes Supplements Market Share by Region (2020-2025)
Table 8. Global Diabetes Supplements Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Diabetes Supplements Market Share by Region (2026-2031)
Table 10. Diabetes Supplements Market Trends
Table 11. Diabetes Supplements Market Drivers
Table 12. Diabetes Supplements Market Challenges
Table 13. Diabetes Supplements Market Restraints
Table 14. Global Diabetes Supplements Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Diabetes Supplements Market Share by Players (2020-2025)
Table 16. Global Top Diabetes Supplements Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Supplements as of 2024)
Table 17. Ranking of Global Top Diabetes Supplements Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Diabetes Supplements Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Diabetes Supplements, Headquarters and Area Served
Table 20. Global Key Players of Diabetes Supplements, Product and Application
Table 21. Global Key Players of Diabetes Supplements, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Diabetes Supplements Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Diabetes Supplements Revenue Market Share by Type (2020-2025)
Table 25. Global Diabetes Supplements Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Diabetes Supplements Revenue Market Share by Type (2026-2031)
Table 27. Global Diabetes Supplements Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Diabetes Supplements Revenue Market Share by Application (2020-2025)
Table 29. Global Diabetes Supplements Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Diabetes Supplements Revenue Market Share by Application (2026-2031)
Table 31. North America Diabetes Supplements Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Diabetes Supplements Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Diabetes Supplements Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Diabetes Supplements Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Diabetes Supplements Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Diabetes Supplements Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Diabetes Supplements Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Diabetes Supplements Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Diabetes Supplements Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Diabetes Supplements Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Diabetes Supplements Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Diabetes Supplements Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Diabetes Supplements Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Diabetes Supplements Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Diabetes Supplements Market Size by Country (2026-2031) & (US$ Million)
Table 46. Novo Nordisk Company Details
Table 47. Novo Nordisk Business Overview
Table 48. Novo Nordisk Diabetes Supplements Product
Table 49. Novo Nordisk Revenue in Diabetes Supplements Business (2020-2025) & (US$ Million)
Table 50. Novo Nordisk Recent Development
Table 51. Nestlé Health Science Company Details
Table 52. Nestlé Health Science Business Overview
Table 53. Nestlé Health Science Diabetes Supplements Product
Table 54. Nestlé Health Science Revenue in Diabetes Supplements Business (2020-2025) & (US$ Million)
Table 55. Nestlé Health Science Recent Development
Table 56. Danone Nutricia Company Details
Table 57. Danone Nutricia Business Overview
Table 58. Danone Nutricia Diabetes Supplements Product
Table 59. Danone Nutricia Revenue in Diabetes Supplements Business (2020-2025) & (US$ Million)
Table 60. Danone Nutricia Recent Development
Table 61. NaturoGain Company Details
Table 62. NaturoGain Business Overview
Table 63. NaturoGain Diabetes Supplements Product
Table 64. NaturoGain Revenue in Diabetes Supplements Business (2020-2025) & (US$ Million)
Table 65. NaturoGain Recent Development
Table 66. Nature's Sunshine Forms Company Details
Table 67. Nature's Sunshine Forms Business Overview
Table 68. Nature's Sunshine Forms Diabetes Supplements Product
Table 69. Nature's Sunshine Forms Revenue in Diabetes Supplements Business (2020-2025) & (US$ Million)
Table 70. Nature's Sunshine Forms Recent Development
Table 71. Nature's Bounty Company Details
Table 72. Nature's Bounty Business Overview
Table 73. Nature's Bounty Diabetes Supplements Product
Table 74. Nature's Bounty Revenue in Diabetes Supplements Business (2020-2025) & (US$ Million)
Table 75. Nature's Bounty Recent Development
Table 76. Glucose Health, Inc Company Details
Table 77. Glucose Health, Inc Business Overview
Table 78. Glucose Health, Inc Diabetes Supplements Product
Table 79. Glucose Health, Inc Revenue in Diabetes Supplements Business (2020-2025) & (US$ Million)
Table 80. Glucose Health, Inc Recent Development
Table 81. Unilever(Horlicks Cardia +) Company Details
Table 82. Unilever(Horlicks Cardia +) Business Overview
Table 83. Unilever(Horlicks Cardia +) Diabetes Supplements Product
Table 84. Unilever(Horlicks Cardia +) Revenue in Diabetes Supplements Business (2020-2025) & (US$ Million)
Table 85. Unilever(Horlicks Cardia +) Recent Development
Table 86. Bionova Lifesciences Company Details
Table 87. Bionova Lifesciences Business Overview
Table 88. Bionova Lifesciences Diabetes Supplements Product
Table 89. Bionova Lifesciences Revenue in Diabetes Supplements Business (2020-2025) & (US$ Million)
Table 90. Bionova Lifesciences Recent Development
Table 91. Caelus Health Company Details
Table 92. Caelus Health Business Overview
Table 93. Caelus Health Diabetes Supplements Product
Table 94. Caelus Health Revenue in Diabetes Supplements Business (2020-2025) & (US$ Million)
Table 95. Caelus Health Recent Development
Table 96. Abbott Company Details
Table 97. Abbott Business Overview
Table 98. Abbott Diabetes Supplements Product
Table 99. Abbott Revenue in Diabetes Supplements Business (2020-2025) & (US$ Million)
Table 100. Abbott Recent Development
Table 101. Pfizer Company Details
Table 102. Pfizer Business Overview
Table 103. Pfizer Diabetes Supplements Product
Table 104. Pfizer Revenue in Diabetes Supplements Business (2020-2025) & (US$ Million)
Table 105. Pfizer Recent Development
Table 106. Arkopharma Laboratories Company Details
Table 107. Arkopharma Laboratories Business Overview
Table 108. Arkopharma Laboratories Diabetes Supplements Product
Table 109. Arkopharma Laboratories Revenue in Diabetes Supplements Business (2020-2025) & (US$ Million)
Table 110. Arkopharma Laboratories Recent Development
Table 111. GlaxoSmithKline Company Details
Table 112. GlaxoSmithKline Business Overview
Table 113. GlaxoSmithKline Diabetes Supplements Product
Table 114. GlaxoSmithKline Revenue in Diabetes Supplements Business (2020-2025) & (US$ Million)
Table 115. GlaxoSmithKline Recent Development
Table 116. Archer Daniels Midland Company Details
Table 117. Archer Daniels Midland Business Overview
Table 118. Archer Daniels Midland Diabetes Supplements Product
Table 119. Archer Daniels Midland Revenue in Diabetes Supplements Business (2020-2025) & (US$ Million)
Table 120. Archer Daniels Midland Recent Development
Table 121. Herbalife International Company Details
Table 122. Herbalife International Business Overview
Table 123. Herbalife International Diabetes Supplements Product
Table 124. Herbalife International Revenue in Diabetes Supplements Business (2020-2025) & (US$ Million)
Table 125. Herbalife International Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
Table 129. Authors List of This Report
List of Figures
Figure 1. Diabetes Supplements Picture
Figure 2. Global Diabetes Supplements Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Diabetes Supplements Market Share by Type: 2024 VS 2031
Figure 4. By Supplements Type Features
Figure 5. By Dosage Form Features
Figure 6. Global Diabetes Supplements Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Diabetes Supplements Market Share by Application: 2024 VS 2031
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Diabetes Supplements Report Years Considered
Figure 12. Global Diabetes Supplements Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Diabetes Supplements Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Diabetes Supplements Market Share by Region: 2024 VS 2031
Figure 15. Global Diabetes Supplements Market Share by Players in 2024
Figure 16. Global Top Diabetes Supplements Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Supplements as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Diabetes Supplements Revenue in 2024
Figure 18. North America Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Diabetes Supplements Market Share by Country (2020-2031)
Figure 20. United States Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Diabetes Supplements Market Share by Country (2020-2031)
Figure 24. Germany Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Diabetes Supplements Market Share by Region (2020-2031)
Figure 32. China Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Diabetes Supplements Market Share by Country (2020-2031)
Figure 40. Mexico Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Diabetes Supplements Market Share by Country (2020-2031)
Figure 44. Turkey Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Novo Nordisk Revenue Growth Rate in Diabetes Supplements Business (2020-2025)
Figure 48. Nestlé Health Science Revenue Growth Rate in Diabetes Supplements Business (2020-2025)
Figure 49. Danone Nutricia Revenue Growth Rate in Diabetes Supplements Business (2020-2025)
Figure 50. NaturoGain Revenue Growth Rate in Diabetes Supplements Business (2020-2025)
Figure 51. Nature's Sunshine Forms Revenue Growth Rate in Diabetes Supplements Business (2020-2025)
Figure 52. Nature's Bounty Revenue Growth Rate in Diabetes Supplements Business (2020-2025)
Figure 53. Glucose Health, Inc Revenue Growth Rate in Diabetes Supplements Business (2020-2025)
Figure 54. Unilever(Horlicks Cardia +) Revenue Growth Rate in Diabetes Supplements Business (2020-2025)
Figure 55. Bionova Lifesciences Revenue Growth Rate in Diabetes Supplements Business (2020-2025)
Figure 56. Caelus Health Revenue Growth Rate in Diabetes Supplements Business (2020-2025)
Figure 57. Abbott Revenue Growth Rate in Diabetes Supplements Business (2020-2025)
Figure 58. Pfizer Revenue Growth Rate in Diabetes Supplements Business (2020-2025)
Figure 59. Arkopharma Laboratories Revenue Growth Rate in Diabetes Supplements Business (2020-2025)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Diabetes Supplements Business (2020-2025)
Figure 61. Archer Daniels Midland Revenue Growth Rate in Diabetes Supplements Business (2020-2025)
Figure 62. Herbalife International Revenue Growth Rate in Diabetes Supplements Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Diabetes Supplements Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of By Supplements Type
Table 3. Key Players of By Dosage Form
Table 4. Global Diabetes Supplements Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Diabetes Supplements Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Diabetes Supplements Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Diabetes Supplements Market Share by Region (2020-2025)
Table 8. Global Diabetes Supplements Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Diabetes Supplements Market Share by Region (2026-2031)
Table 10. Diabetes Supplements Market Trends
Table 11. Diabetes Supplements Market Drivers
Table 12. Diabetes Supplements Market Challenges
Table 13. Diabetes Supplements Market Restraints
Table 14. Global Diabetes Supplements Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Diabetes Supplements Market Share by Players (2020-2025)
Table 16. Global Top Diabetes Supplements Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Supplements as of 2024)
Table 17. Ranking of Global Top Diabetes Supplements Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Diabetes Supplements Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Diabetes Supplements, Headquarters and Area Served
Table 20. Global Key Players of Diabetes Supplements, Product and Application
Table 21. Global Key Players of Diabetes Supplements, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Diabetes Supplements Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Diabetes Supplements Revenue Market Share by Type (2020-2025)
Table 25. Global Diabetes Supplements Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Diabetes Supplements Revenue Market Share by Type (2026-2031)
Table 27. Global Diabetes Supplements Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Diabetes Supplements Revenue Market Share by Application (2020-2025)
Table 29. Global Diabetes Supplements Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Diabetes Supplements Revenue Market Share by Application (2026-2031)
Table 31. North America Diabetes Supplements Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Diabetes Supplements Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Diabetes Supplements Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Diabetes Supplements Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Diabetes Supplements Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Diabetes Supplements Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Diabetes Supplements Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Diabetes Supplements Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Diabetes Supplements Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Diabetes Supplements Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Diabetes Supplements Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Diabetes Supplements Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Diabetes Supplements Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Diabetes Supplements Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Diabetes Supplements Market Size by Country (2026-2031) & (US$ Million)
Table 46. Novo Nordisk Company Details
Table 47. Novo Nordisk Business Overview
Table 48. Novo Nordisk Diabetes Supplements Product
Table 49. Novo Nordisk Revenue in Diabetes Supplements Business (2020-2025) & (US$ Million)
Table 50. Novo Nordisk Recent Development
Table 51. Nestlé Health Science Company Details
Table 52. Nestlé Health Science Business Overview
Table 53. Nestlé Health Science Diabetes Supplements Product
Table 54. Nestlé Health Science Revenue in Diabetes Supplements Business (2020-2025) & (US$ Million)
Table 55. Nestlé Health Science Recent Development
Table 56. Danone Nutricia Company Details
Table 57. Danone Nutricia Business Overview
Table 58. Danone Nutricia Diabetes Supplements Product
Table 59. Danone Nutricia Revenue in Diabetes Supplements Business (2020-2025) & (US$ Million)
Table 60. Danone Nutricia Recent Development
Table 61. NaturoGain Company Details
Table 62. NaturoGain Business Overview
Table 63. NaturoGain Diabetes Supplements Product
Table 64. NaturoGain Revenue in Diabetes Supplements Business (2020-2025) & (US$ Million)
Table 65. NaturoGain Recent Development
Table 66. Nature's Sunshine Forms Company Details
Table 67. Nature's Sunshine Forms Business Overview
Table 68. Nature's Sunshine Forms Diabetes Supplements Product
Table 69. Nature's Sunshine Forms Revenue in Diabetes Supplements Business (2020-2025) & (US$ Million)
Table 70. Nature's Sunshine Forms Recent Development
Table 71. Nature's Bounty Company Details
Table 72. Nature's Bounty Business Overview
Table 73. Nature's Bounty Diabetes Supplements Product
Table 74. Nature's Bounty Revenue in Diabetes Supplements Business (2020-2025) & (US$ Million)
Table 75. Nature's Bounty Recent Development
Table 76. Glucose Health, Inc Company Details
Table 77. Glucose Health, Inc Business Overview
Table 78. Glucose Health, Inc Diabetes Supplements Product
Table 79. Glucose Health, Inc Revenue in Diabetes Supplements Business (2020-2025) & (US$ Million)
Table 80. Glucose Health, Inc Recent Development
Table 81. Unilever(Horlicks Cardia +) Company Details
Table 82. Unilever(Horlicks Cardia +) Business Overview
Table 83. Unilever(Horlicks Cardia +) Diabetes Supplements Product
Table 84. Unilever(Horlicks Cardia +) Revenue in Diabetes Supplements Business (2020-2025) & (US$ Million)
Table 85. Unilever(Horlicks Cardia +) Recent Development
Table 86. Bionova Lifesciences Company Details
Table 87. Bionova Lifesciences Business Overview
Table 88. Bionova Lifesciences Diabetes Supplements Product
Table 89. Bionova Lifesciences Revenue in Diabetes Supplements Business (2020-2025) & (US$ Million)
Table 90. Bionova Lifesciences Recent Development
Table 91. Caelus Health Company Details
Table 92. Caelus Health Business Overview
Table 93. Caelus Health Diabetes Supplements Product
Table 94. Caelus Health Revenue in Diabetes Supplements Business (2020-2025) & (US$ Million)
Table 95. Caelus Health Recent Development
Table 96. Abbott Company Details
Table 97. Abbott Business Overview
Table 98. Abbott Diabetes Supplements Product
Table 99. Abbott Revenue in Diabetes Supplements Business (2020-2025) & (US$ Million)
Table 100. Abbott Recent Development
Table 101. Pfizer Company Details
Table 102. Pfizer Business Overview
Table 103. Pfizer Diabetes Supplements Product
Table 104. Pfizer Revenue in Diabetes Supplements Business (2020-2025) & (US$ Million)
Table 105. Pfizer Recent Development
Table 106. Arkopharma Laboratories Company Details
Table 107. Arkopharma Laboratories Business Overview
Table 108. Arkopharma Laboratories Diabetes Supplements Product
Table 109. Arkopharma Laboratories Revenue in Diabetes Supplements Business (2020-2025) & (US$ Million)
Table 110. Arkopharma Laboratories Recent Development
Table 111. GlaxoSmithKline Company Details
Table 112. GlaxoSmithKline Business Overview
Table 113. GlaxoSmithKline Diabetes Supplements Product
Table 114. GlaxoSmithKline Revenue in Diabetes Supplements Business (2020-2025) & (US$ Million)
Table 115. GlaxoSmithKline Recent Development
Table 116. Archer Daniels Midland Company Details
Table 117. Archer Daniels Midland Business Overview
Table 118. Archer Daniels Midland Diabetes Supplements Product
Table 119. Archer Daniels Midland Revenue in Diabetes Supplements Business (2020-2025) & (US$ Million)
Table 120. Archer Daniels Midland Recent Development
Table 121. Herbalife International Company Details
Table 122. Herbalife International Business Overview
Table 123. Herbalife International Diabetes Supplements Product
Table 124. Herbalife International Revenue in Diabetes Supplements Business (2020-2025) & (US$ Million)
Table 125. Herbalife International Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
Table 129. Authors List of This Report
List of Figures
Figure 1. Diabetes Supplements Picture
Figure 2. Global Diabetes Supplements Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Diabetes Supplements Market Share by Type: 2024 VS 2031
Figure 4. By Supplements Type Features
Figure 5. By Dosage Form Features
Figure 6. Global Diabetes Supplements Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Diabetes Supplements Market Share by Application: 2024 VS 2031
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Diabetes Supplements Report Years Considered
Figure 12. Global Diabetes Supplements Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Diabetes Supplements Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Diabetes Supplements Market Share by Region: 2024 VS 2031
Figure 15. Global Diabetes Supplements Market Share by Players in 2024
Figure 16. Global Top Diabetes Supplements Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Supplements as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Diabetes Supplements Revenue in 2024
Figure 18. North America Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Diabetes Supplements Market Share by Country (2020-2031)
Figure 20. United States Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Diabetes Supplements Market Share by Country (2020-2031)
Figure 24. Germany Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Diabetes Supplements Market Share by Region (2020-2031)
Figure 32. China Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Diabetes Supplements Market Share by Country (2020-2031)
Figure 40. Mexico Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Diabetes Supplements Market Share by Country (2020-2031)
Figure 44. Turkey Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Diabetes Supplements Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Novo Nordisk Revenue Growth Rate in Diabetes Supplements Business (2020-2025)
Figure 48. Nestlé Health Science Revenue Growth Rate in Diabetes Supplements Business (2020-2025)
Figure 49. Danone Nutricia Revenue Growth Rate in Diabetes Supplements Business (2020-2025)
Figure 50. NaturoGain Revenue Growth Rate in Diabetes Supplements Business (2020-2025)
Figure 51. Nature's Sunshine Forms Revenue Growth Rate in Diabetes Supplements Business (2020-2025)
Figure 52. Nature's Bounty Revenue Growth Rate in Diabetes Supplements Business (2020-2025)
Figure 53. Glucose Health, Inc Revenue Growth Rate in Diabetes Supplements Business (2020-2025)
Figure 54. Unilever(Horlicks Cardia +) Revenue Growth Rate in Diabetes Supplements Business (2020-2025)
Figure 55. Bionova Lifesciences Revenue Growth Rate in Diabetes Supplements Business (2020-2025)
Figure 56. Caelus Health Revenue Growth Rate in Diabetes Supplements Business (2020-2025)
Figure 57. Abbott Revenue Growth Rate in Diabetes Supplements Business (2020-2025)
Figure 58. Pfizer Revenue Growth Rate in Diabetes Supplements Business (2020-2025)
Figure 59. Arkopharma Laboratories Revenue Growth Rate in Diabetes Supplements Business (2020-2025)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Diabetes Supplements Business (2020-2025)
Figure 61. Archer Daniels Midland Revenue Growth Rate in Diabetes Supplements Business (2020-2025)
Figure 62. Herbalife International Revenue Growth Rate in Diabetes Supplements Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232